Continuing to drive change in 2024

As we enter a new year, our end goal remains the same – to inspire action and drive change. We are always on the lookout for ways to enhance the insights we bring to our clients, whether we are using innovative technology with agility, understanding behaviour, or applying robust methods to lead to more reliable market predictions.

2023 was a great year for Adelphi Research; we continued to fulfil our commitment to meaningful insights and ensured patients remained at the heart of our pharmaceutical business strategy. For over two decades we have created a culture of purposeful and innovative thinking, which enables our team to experiment with science-based methods. Last year, we succeeded in servicing 50 global pharmaceutical companies, raising $250k for global charities and working with over 108 therapies across 27 countries worldwide. We also engaged with 80,000 people to understand their health experiences through interviews and surveys across the globe.

As science and technology progresses, we continue to evolve, embracing Artificial Intelligence (AI) smartly to accelerate and deepen insights. We are excited to continue to grow as a business and to support our clients in new ways.

Click here to watch our 2023 video highlights.